Synergy CHC Q1 2025 Earnings Report

Synergy CHC EPS Results

• Actual EPS: $0.10
• Consensus EPS: $0.07
• Beat/Miss: Beat by +$0.03
• One Year Ago EPS: N/A

Synergy CHC Revenue Results

• Actual Revenue: $8.17 million
• Expected Revenue: $9.03 million
• Beat/Miss: Missed by -$860.00 thousand
• YoY Revenue Growth: N/A

Synergy CHC Announcement Details

• Quarter: Q1 2025
• Date: 5/15/2025
• Time: Before Market Opens
• Conference Call Date: Thursday, May 15, 2025
• Conference Call Time: 9:00AM ET

Synergy CHC (NASDAQ:SNYR) engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

Synergy CHC Q1 2025 Earnings Call Transcript

Key Takeaways

• Synergy delivered a 30% growth in earnings per share year-over-year—their ninth consecutive profitable quarter—with EBITDA margins expanding to 24.1% from 19.7%, reflecting strong cost discipline.
• First-quarter net revenue declined 13% to $8.2 million versus $9.4 million a year ago, driven by the absence of a one-time sell-in, while cash and equivalents fell to $178,000 at quarter end.
• International expansion is underway with a three-year UAE license for the Focus Factor brand (revenue starting Q4), a new Mexican subsidiary targeting Costco and Walmart (revenue early Q3), and planned Costco-led launches in Australia and Taiwan in Q4.
• RTD beverage business gained momentum—hiring a seasoned industry veteran, adding over 400 Canadian convenience stores, and securing nearly $1 million in Amazon purchase orders in Q2, with full rollout expected in the back half of the year.
• Synergy has two term sheets in place to refinance debt, extend maturities into 2029, and defer over $10 million of principal payments in 2025, which should accelerate free cash flow.

Presentation

[Operator]

Good morning, everyone, and thank you for participating in today's Conference Call to discuss Synergy CHC Corporation's Financial Results for the First Quarter ended March 31, 2025. Joining us today are Synergy CEO Jack Ross, CFO Jaime Fickett, and Greg Robles with Investor Relations. Following their remarks, we'll open the call for analyst questions. Before we go further, I would like to turn the call over to Mr. Robles as he reads the company's Safe Harbor statement. Greg, please go ahead.

[Greg Robles, Director of Investor Relations at Synergy CHC Corp]

Thanks, Marvin. Good morning, and thanks for joining our conference call to discuss our first quarter 2025 financial results. I'd like to remind everyone that this call is available for replay and via a live webcast that will be posted on our Investor Relations site at investors.synergychc.com. The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's SEC filings under the captioned risk factors.

[Greg Robles, Director of Investor Relations at Synergy CHC Corp]

The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now, I would like to turn the call over to the CEO of Synergy, Jack Ross. Jack?

[Jack Ross, CEO at Synergy CHC Corp]

Yes. Good morning, everyone. Thank you for joining us today to discuss Synergy's performance for the first quarter of 2025. We are very pleased to report a 30% growth in earnings per share year over year, marking our ninth consecutive quarter of profitability. Additionally, we have expanded our EBITDA margins significantly to 24.1% compared to 19.7% in the prior period. This performance highlights the strength of our operating model and the ongoing discipline around cost management. Before we get into the results, I want to highlight a few exciting business developments that the team has been working diligently on. First, as an update on our international expansion, we have entered into a three-year license agreement for the Focus Factor brand with a company in the United Arab Emirates, which allows Focus Factor to expand its global reach.

[Jack Ross, CEO at Synergy CHC Corp]

We expect the licensee and their designated territory to begin generating revenue by the fourth quarter. Looking ahead, we plan to expand our global presence by adding new licensees in selected markets where Synergy does not currently operate and does not intend to establish a direct footprint. Additionally, we have incorporated a wholly owned subsidiary in Mexico, and we are working on onboarding our manufacturing partners and customers, which includes Costco and Walmart. We expect this initiative to start generating revenue early in the third quarter. We still intend to open Australia and Taiwan markets early in the fourth quarter, with Costco being the lead customer for both regions. Second, I would like to provide an update on our RTD beverage progress. We have hired an industry veteran with over 10 years of experience in the beverage and convenience store industry.

[Jack Ross, CEO at Synergy CHC Corp]

He is set to join our team on May 26th. We expect him to add significant growth to our beverage business starting almost immediately. Since our last call in March, we now have opened more than 400 additional convenience stores in Canada, doing business with Metro, En-Route, INS markets, to name a few. Moving forward, we will continue to grow our Canadian and U.S. convenience store business for our RTD beverages. We are pleased to report that during the second quarter, we received nearly $1 million of purchase orders from Amazon for our RTD products. These orders represent strong momentum through the second quarter. We expect to be in full rollout mode with Amazon and other major retailers in the back half of the year. Third, we have entered into a long-term supplier agreement for Focus Factor products, which will have significant cost-saving benefits to Synergy.

[Jack Ross, CEO at Synergy CHC Corp]

This arrangement has changed our capital needs from Synergy buying and owning the inventory for the Focus Factor brand to the supplier now owning the inventory and shipping directly to our customers. Lastly, we also have entered into two term sheets to refinance our debt that we expect to close as soon as possible, which is expected to accelerate free cash flow in the business in the near term and extend our debt maturity date into 2029. With the terms that are currently being presented, this refinancing will alleviate more than $10 million of principal payments in 2025. Before passing the call over to Jaime, I want to touch briefly on tariffs, as we know this evolving situation is on top of the mind of all investors. Synergy purchases all its products from suppliers in their representative countries, meaning all products sold within a country are produced in that country.

[Jack Ross, CEO at Synergy CHC Corp]

While we may see some impact from tariffs on certain ingredients, we do not expect to have any material impact on our business. With those updates, I'd like to turn the call over to our Chief Financial Officer, Jaime Fickett. Jaime?

[Jaime Fickett, CFO at Synergy CHC Corp]

Thank you, Jack. I'll now review our financial results. For the first quarter of 2025, net revenue was $8.2 million compared to $9.4 million in the year-ago quarter, reflecting a 13% decrease year over year. This decline was primarily driven by a one-time sell-in to one customer during 2024 that did not repeat in 2025. Gross margin for the first quarter was 75.4% compared to 72% in the same quarter last year. The increase in gross margin was primarily driven by a favorable product mix. Operating expenses for the first quarter were $4.2 million compared to $5 million in the year-ago quarter. The decrease of 15% in operating expenses reflects our ongoing focus on managing costs effectively while continuing to invest in key growth initiatives. Income from operations was $1.9 million, an increase of 8% compared to $1.8 million in the first quarter of 2024.

[Jaime Fickett, CFO at Synergy CHC Corp]

Net income for the first quarter was $876,000, or $0.10 per diluted share, compared to $580,000, or $0.08 per diluted share in the year-ago quarter. This represents a 30% increase in earnings per share year over year, reflecting the successful execution of our strategic growth initiatives and cost management. EBITDA for the first quarter was $1.98 million compared to $1.85 million in the first quarter of 2024, up 7%. Moving to our balance sheet. As of March 31, 2025, we had cash and cash equivalents of $177,900 compared to $687,900 as of December 31, 2024. Inventory was $2.3 million at the end of the first quarter compared to $1.7 million at the end of December 31, 2024.

[Jaime Fickett, CFO at Synergy CHC Corp]

At March 31st, 2025, we had $31.3 million in total liabilities, which compares to $33 million in total liabilities at December 31st, 2024, which is a decrease of $1.7 million in the first quarter. For the three months ended March 31st, 2025, our cash used in operating activities was $823,000 compared to cash used in operating activities of $858,000 at March 31st, 2024. The decrease was primarily attributable to an increase in inventory and a decrease in accounts payable and accrued expenses offset by a decrease in receivables. Now, I will turn the call back over to the operator.

[Operator]

Thank you. At this time, we'll conduct the question-and-answer session. To ask a question, you will need to press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. Please stand by while I compile the Q&A roster. Our first question comes from the line of Sean McGowan of Roth Capital Partners. Please proceed.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Good morning. Thanks for taking the questions. My first question would be on the RTD beverage. So how much was in the quarter, and kind of what are the plans for the rollout for the remainder of the year?

[Jack Ross, CEO at Synergy CHC Corp]

Yeah, Sean, thank you for the question. If you sort of look at Synergy's budget, we did not have really anything planned for the first quarter. We did $30,000 of RTD revenue in the first quarter. In the second quarter, with what has happened already with Amazon, we expect to do about $2 million.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Okay. In terms of kind of geographic territories and other distribution channels, what's the plan for the balance of the year?

[Jack Ross, CEO at Synergy CHC Corp]

For RTDs?

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Yeah, yeah. In terms of adding new stores and new customers.

[Jack Ross, CEO at Synergy CHC Corp]

Yeah. So primarily just in Canada and the U.S. at this point, and nothing's changed from the major customers that we are targeting, meaning convenience stores. Obviously, we're going to go back to Costco and the rest of the retailers that we already have in our system that we sell our current bills to.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Okay. And then a question on expenses. Good job there. They came in below where I thought. Would you say this G&A level is going to rise through the year, or is this something we should expect to see consistently through the year?

[Jack Ross, CEO at Synergy CHC Corp]

G&A, we will have a couple of headcount adds, if you will, to G&A, but I think it'll be as a percentage, it will probably be pretty flat.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Okay. My last question was, what was the licensing revenue that you booked in the first quarter there? Is that something you've talked about before? I thought that was stuff that we would expect later in the year.

[Jack Ross, CEO at Synergy CHC Corp]

Yeah. As mentioned in my dialogue on the call here, we signed a licensee for the United Arab Emirates that we received a fee for $1.5 million for that territory, and we will pursue other territories that way that we do not plan on having a footprint ourselves in, if you will. Expanding our global reach, basically.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

In the future, then, for at least that particular contract, that would be just based on the actual revenue, and this is just sort of a startup fee?

[Jack Ross, CEO at Synergy CHC Corp]

That's correct.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Okay.

[Jack Ross, CEO at Synergy CHC Corp]

In the fourth quarter, they got a bit of registration timeline to start generating revenue, but we expect to start generating revenue in the fourth quarter.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Okay. Thank you. Just one more clarification. Did you mention Australia and Thailand? Were those the two countries you expected?

[Jack Ross, CEO at Synergy CHC Corp]

Taiwan.

[Sean McGowan, Managing Director of Equity Research at Roth Capital Partners]

Taiwan. Okay. Thank you.

[Operator]

Thank you. As a reminder, to ask a question, you will need to press star 11 on your telephone. At this time, I'm showing no questions. I'll now turn the call back over to Mr. Ross for closing remarks.

[Jack Ross, CEO at Synergy CHC Corp]

Thank you. We'd like to thank everyone for joining our earnings call, and we look forward to speaking with you when we report the second quarter results in August. Thank you.

[Operator]

Ladies and gentlemen, this concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.

Participants

Executives

• Jaime Fickett, CFO
• Greg Robles, Director of Investor Relations
• Jack Ross, CEO

Analysts

• Sean McGowan, Managing Director of Equity Research at Roth Capital Partners